Study Group: Aloxi Prescribers for CINV: Oncologists (US)(?)
Council Members in this Study Group: 47
Request a survey with this Study Group
Leading Experts in this Study Group
Donald Fleming, MDDivision Head of Hematology and Oncology
Davis Health System, Inc.
Donald Fleming, MD, is the Head of Hematology-Oncology at the Medical Center of Vincennes. Previously, Dr. Fleming was a Tenured Professor in the Division of Hematology-Oncology at University of Louisville. He has published over 25 manuscripts in peer-reviewed journals and remains involved in clinical...
Consultant
Medical Consulting Firm of Dr. Ben Ebrahimi
Ben Ebrahimi, MD, is Director of Clinical Trials at Wilshire Oncology Medical Group. Dr. Ebrahimi oversees clinical trials in various tumor types and treats a variety of cancer patients including lung, breast, colorectal, and lymphomas. These clinical trials include biological agents as well as targeted...
Taral Patel, MDOncologist
Mid Ohio Oncology Hematology Inc.
Taral Patel, MD, is an Oncologist in private practice with Mid Ohio Oncology-Hematology, Inc. He treats patients with both cancer and blood disorders. Dr. Patel has been a principal investigator for multiple clinical trials in colon cancer, lung cancer, lymphoma, and growth factor. He has been on the...
Professor of Clinical Medicine
Columbia University College of Physicians and Surgeons
Michael Grossbard, MD, is a Professor of Clinical Medicine at Columbia University College of Physicians and Surgeons and the Chief of Hematology-Oncology at St. Luke's-Roosevelt Hospital and Beth Israel Medical Center in New York City. His clinical research is in monoclonal antibodies, non-Hodgkin's...
Brian Abbott, MDMedical Director of Hematology
Big Sky Oncology
Brian Abbott, MD, is the Medical Director of Hematology at Big Sky Oncology and Sletten Cancer Institute in Great Falls, Montana. His specialties include acute and chronic leukemias (AML, ALL, CML, CLL), all forms of lymphomas including Non-Hodgkin’s and Hodgkin's Lymphoma, myelomas, bone and marrow...
Assistant Professor of Medicine
New York University School of Medicine/ Medical Center
James D'Olimpio, MD, FACP, is the Director of Palliative Medicine/Cancer Pain and Supportive Oncology at North Shore University Hospital/Monter Cancer Center in Manhasset, New York, and an Assistant Professor of Medicine at New York University School of Medicine. His expertise includes a wide range...
Related Study Groups
| Study Group Name | Members |
|---|---|
| Oncologists (US) | 2247 |
| Aloxi Prescribers for CINV (US) | 38 |
| SRA Prescribers (US) | 47 |
| Oncologists who Treat Hematologic Malignancies (US) | 881 |
| Hematologists (US) | 1019 |
| Oncologists in Private Practice in the U.S. | 431 |
| Hematologists and Oncologists in Private Practice (US) | 442 |
GLG NewsSMAnalyses by this Study Group's Leading Experts(?)
NICE has stated that the cost of several novel agents for the treatment of renal cell cancer including Sutent, Torisel, Avastin, and Nexavar exceeds the benefit when assessed by quality adjusted life years (QALY) gained from the therapies.
In this election year some have encouraged adoption of socialized medical services UK healthcare is an example of what some in this country have said we need to model our future healthcare system The recent use of biologics such as the TKIs have resulted in options for...
Recent BMS subanalysis indicate despite negative trial, EGFR indicates favorable outcome with platinum therapy EGFR will become target for frontline NSCLCa
The cost of medical care is increasing at an alarming rate The amount of money to support a physician's practice is going down at the same alarming rate especially in oncology
Lilly has devoted substantial energy/expense in developing Cymbalta for many indications. Is this at the expense of developing novel agents?
Most Common Company Types:
- Office Based Private Practice or Clinic
- Academic Medical Center/Hospital or Clinic
- Non-Academic Community Hospital or Clinic
- Other Freestanding Healthcare Facility
Most Common Job Types:
- Physician - Attending Physician
- Physician - Director
- Partner
- Physician - Division Head
- Medical Director
- Owner
GLG's 750+ Clients Include:
global mutual funds
global banks
private equity firms

